Dolutegravir and Lamivudine

Dovato

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $105.2874

No Shortage Tier 1: 17.9%

Dolutegravir and Lamivudine suppresses hepatitis B virus replication.

vs. brand Dovato: Generic saves up to -953% per unit

Covered Lives

Generic Manufacturers

VIIV HEALTHCARE CO

Explore in the Ecosystem

rxsaver.aiCompare prices for Dolutegravir and Lamivudine drfinder.aiFind doctors who prescribe Dolutegravir and Lamivudine rxnews.aiLatest news about Dolutegravir and Lamivudine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.